Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors
K. Shibata, F. Kikkawa, M. Mika, Y. Suzuki, H. Kajiyama, K. Ino, S. Mizutani
International Journal of Gynecologic Cancer Aug 2003, 13 (5) 587-592; DOI: 10.1136/ijgc-00009577-200309000-00003